Last Price Today's Change   Day's Range   Trading Volume
1.86   +0.01 (0.54%)  1.85 - 1.86  100

Dividend, Bonus, Split & Consolidation

Hints :
[1] Click the View Entitlement icon table to view the Entitlement detail page.

Click here to modify the Visible Columns.

Ann. Date Ex Date Payment Date Type Subject Amount View
28-Jun-2019 27-Jun-2019 18-Jul-2019 DIVIDEND REPL::Cash Dividend/ Distribution::Mandatory SGD 0.0098 Dividend Detail
29-Apr-2019 27-Jun-2019 18-Jul-2019 DIVIDEND REPL::Cash Dividend/ Distribution::Mandatory SGD 0.03 Dividend Detail
28-Mar-2019 27-Jun-2019 18-Jul-2019 DIVIDEND Cash Dividend/ Distribution::Mandatory SGD 0.03 Dividend Detail
29-Jun-2018 27-Jun-2018 18-Jul-2018 DIVIDEND REPL::Cash Dividend/ Distribution::Mandatory SGD 0.0101 Dividend Detail
26-Mar-2018 27-Jun-2018 18-Jul-2018 DIVIDEND Cash Dividend/ Distribution::Mandatory SGD 0.03 Dividend Detail
30-Jun-2017 28-Jun-2017 18-Jul-2017 DIVIDEND REPL::Cash Dividend/ Distribution::Mandatory SGD 0.0096 Dividend Detail

  2 people like this.
edcheong A stock to add to your portfolio in these bad times.
26/07/2012 2:44 PM
Stephen Lee Beaware of this stock which is listed in SGX and KLSE. These are cronies political stock which was owned by our one timed former PM Mathier. The crossed border listing of stocks on both side of SGX and KLSE was closed by former PM Dr. Mathier due to the financial crisis in 1997. Backgorund...who control Parkmay the forerunner of IHH? Whom was Vincent Tan of Berjaya Group whom has recently stepped down are the runner for Big Boss....Who is the Big Boss whose office is registerd in Bangsar, K.L. Please do some reflection.
02/08/2012 5:39 AM
moven00 Eventhough IHH is a little political shares I supposed, but I am thinking this is better than Genting SP for the moment.
Better buy uptrending shares than to buy a downtrend shares.
Just my 2 cents opinion.
Huat ahhhh...
28/08/2012 11:32 PM
tand3 These Sor Hai credit Suisse analyst, misleading people with its target price.

Kindly take note their tp is in MYR not Sin dollar ya. Hence, 3.75 is in RINGGIT MALAYSIA not Sin dollar.

Do your own homework, that's what I can say.
31/08/2012 11:44 AM
moven00 Aha, Now CIMB are more decent. 1.53 is logic, but like the Average Target Price 2.22......
Well, Long term IHH will definitely create value for its shareholders.
The journey have just begin....
04/09/2012 1:18 AM
Jlrh8122 It shd be gd to kp long term....
08/09/2012 7:54 PM
michelle zheng Grossly overvalued stock. If politics is a factor, price should be artificially inflated come election but know when to get out or u will be left holding an overweight baby for a long long time. Hope dividend will make up for it then. Good luck to all invested.
29/09/2012 2:07 PM
sh2383jbt They are two healthcare stock listed SGX, is good for long term under ur portfolio. Raffles medical small but growing slowly , compare PE, IHH is highest.
24/10/2012 11:07 PM
9696_88 what happen drop heavily?
28/08/2013 2:21 PM
inphyy IHH Healthcare may be threatened by a decline in Indonesian patients

HEALTHCARE | Staff Reporter,
Singapore Published: 2 hours 57 min ago

According to CIMB, it thinks that since only 18% of total patients admitted to PPL Singapore come from Indonesia, the net contribution from this group is only about 3% of the group’s PATMI, considering (i) domestic patients’revenue intensity has increase sharply, (ii) more than half of the cases from Indonesian patients are non-elective treatments and (iii) larger contributions from other markets dilute its sensitivity to this risk.

Here's more from CIMB:

2Q13 and 1H13 core earnings were in line, accounting for 22% and 37% of our FY13 numbers. However, we cut FY13-15 estimates by 7-9% as we see more start-up and other opex costsgoing forward.

Our SOP-based target price is reduced as a result. We keep our Outperform rating as we expect a more robust ramp-up of the group’s global operations.

Marked improvement
2Q13 core net profit was driven by growth at its new hospitals, savings in finance costs and the recapitalisation of Acibadem. This offset the depreciation and finance costsrelating to new hospitals that had to be recognised in the P&L after completion.

There was a one-off RM22m tax credit in 2Q13 relating to the tax reversal in Singapore.

There was a marked improvement in the average revenue per inpatient at all of its hospitals in Singapore, Malaysia and Turkey. Excluding the accounting treatment for REIT, all of its business segments recorded revenue growth both yoy and sequentially.

Novena, as predicted, broke even on an EBITDA level in 2Q13. We expect an EBITDA breakeven point for Acibadem Bodrum sometime in 4Q13.
28/08/2013 6:03 PM
inphyy IHH's Q2 profit falls 61% to RM156.8m

Patmi plummets as last year's earnings were boosted by medical suites sale
28/08/2013 6:39 PM
Alex Gray Healthcare provider IHH Healthcare Berhad (SGX: Q0F) slipped by 5.4% to S$1.48. Its second quarter results were also released yesterday evening and they aren’t pretty. Quarterly revenue declined by 38% year-on-year to RM1.68b while profits sank 61% to RM157m.
SGX Stock Picks | Singapore Stock Recommendations | Best Shares to Buy @ (http://goo.gl/chE0k2)
28/08/2013 7:08 PM


95  97  167  744 

Top 10 Active Counters
 Ntegrator Intl 0.013+0.004 
 OEL 0.037+0.008 
 Blumont 0.0030.00 
 GCCP 0.011+0.002 
 AusGroup^ 0.0480.00 
 AsiaPhos 0.0470.00 
 QT Vascular 0.005+0.002 
 Sincap 0.014+0.001 
 Rex Intl 0.196+0.004 
 AsiaMedic 0.0130.00 
Partners & Brokers